Zygmont Chester Stanley III (CIK 1900657) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-18). Recent activity: Buy REVB (208,073 shares), Sell REVB (208,073 shares), Buy REVB (208,073 shares), Sell REVB (13,285 shares), Sell REVB (13,100 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Financial Officer | Buy | 208,073 | $0 |
| 2026-08-18 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Financial Officer | Sell | 208,073 | $0 |
| 2026-08-18 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Financial Officer | Buy | 208,073 | $0 |
| 2026-05-01 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Financial Officer | Sell | 13,285 | $14,614 |
| 2026-02-05 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Financial Officer | Sell | 13,100 | $21,615 |
| 2026-01-12 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Financial Officer | Buy | 78,145 | $70,330 |
| 2025-10-31 | REVELATION BIOSCIENCES, INC. (REVB) | Chief Financial Officer | Buy | 390,614 | $499,986 |
Source: SEC Form 4 filings · as of 2026-08-18